NID1
|
nidogen 1
|
4811
|
P14543
|
chr1: 235,975,830-236,065,162
|
0
|
3
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
405
|
P27540
|
chr1: 150,809,705-150,876,768
|
0
|
1
|
NKG7
|
natural killer cell granule protein 7
|
4818
|
Q16617
|
chr19: 51,371,606-51,372,715
|
0
|
1
|
NKTR
|
natural killer cell triggering receptor
|
4820
|
P30414
|
chr3: 42,600,614-42,648,741
|
0
|
1
|
NMB
|
neuromedin B
|
4828
|
P08949
|
chr15: 84,655,129-84,658,563
|
0
|
1
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
4830
|
P15531
|
chr17: 51,153,536-51,162,428
|
0
|
1
|
NME4
|
NME/NM23 nucleoside diphosphate kinase 4
|
4833
|
O00746
|
chr16: 396,725-410,367
|
0
|
1
|
NQO2
|
NAD(P)H dehydrogenase, quinone 2
|
4835
|
P16083
|
chr6: 2,987,987-3,028,869
|
0
|
1
|
NNMT
|
nicotinamide N-methyltransferase
|
4837
|
P40261
|
chr11: 114,257,787-114,313,285
|
0
|
2
|
NOP2
|
NOP2 nucleolar protein
|
4839
|
P46087
|
chr12: 6,556,863-6,568,691
|
0
|
1
|
NONO
|
non-POU domain containing, octamer-binding
|
4841
|
Q15233
|
chrX: 71,283,192-71,301,168
|
0
|
2
|
NOS3
|
nitric oxide synthase 3
|
4846
|
P29474
|
chr7: 150,990,995-151,014,588
|
2
|
0
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator like
|
406
|
O00327
|
chr11: 13,276,652-13,387,266
|
0
|
1
|
CNOT3
|
CCR4-NOT transcription complex subunit 3
|
4849
|
O75175
|
chr19: 54,137,728-54,155,681
|
0
|
1
|
CNOT4
|
CCR4-NOT transcription complex subunit 4
|
4850
|
O95628
|
chr7: 135,361,795-135,510,127
|
0
|
1
|
NOTCH1
|
notch 1
|
4851
|
P46531
|
chr9: 136,494,444-136,545,862
|
0
|
1
|
NOTCH2
|
notch 2
|
4853
|
Q04721
|
chr1: 119,911,553-120,069,626
|
0
|
1
|
NOVA1
|
neuro-oncological ventral antigen 1
|
4857
|
P51513
|
chr14: 26,443,093-26,597,754
|
0
|
1
|
NOVA2
|
neuro-oncological ventral antigen 2
|
4858
|
Q9UNW9
|
chr19: 45,933,734-45,973,546
|
0
|
1
|
PNP
|
purine nucleoside phosphorylase
|
4860
|
P00491
|
chr14: 20,468,954-20,477,094
|
0
|
1
|
NPAS2
|
neuronal PAS domain protein 2
|
4862
|
Q99743
|
chr2: 100,820,152-100,996,829
|
0
|
1
|
NPAT
|
nuclear protein, ataxia-telangiectasia locus
|
4863
|
Q14207
|
chr11: 108,157,215-108,222,642
|
0
|
2
|
NPC1
|
Niemann-Pick disease, type C1
|
4864
|
O15118
|
chr18: 23,506,184-23,586,898
|
0
|
1
|
ARSA
|
arylsulfatase A
|
410
|
P15289
|
chr22: 50,622,754-50,628,173
|
0
|
1
|
NPHP1
|
nephronophthisis 1 (juvenile)
|
4867
|
O15259
|
chr2: 110,122,311-110,205,066
|
0
|
2
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
4869
|
P06748
|
chr5: 171,387,116-171,411,137
|
0
|
1
|
NPPB
|
natriuretic peptide B
|
4879
|
P16860
|
chr1: 11,857,464-11,858,931
|
2
|
1
|
NPR2
|
natriuretic peptide receptor 2
|
4882
|
P20594
|
chr9: 35,792,154-35,809,732
|
0
|
1
|
NPR3
|
natriuretic peptide receptor 3
|
4883
|
P17342
|
chr5: 32,689,070-32,791,724
|
0
|
3
|
NPTX2
|
neuronal pentraxin II
|
4885
|
P47972
|
chr7: 98,617,297-98,629,868
|
0
|
1
|
NPY1R
|
neuropeptide Y receptor Y1
|
4886
|
P25929
|
chr4: 163,323,961-163,344,832
|
0
|
1
|
NPY2R
|
neuropeptide Y receptor Y2
|
4887
|
P49146
|
chr4: 155,208,629-155,217,078
|
0
|
1
|
NPY6R
|
neuropeptide Y receptor Y6 (pseudogene)
|
4888
|
Q99463
|
chr5: 137,801,193-137,810,751
|
0
|
1
|
NPY5R
|
neuropeptide Y receptor Y5
|
4889
|
Q15761
|
chr4: 163,343,939-163,351,934
|
0
|
1
|
ARSB
|
arylsulfatase B
|
411
|
P15848
|
chr5: 78,777,209-78,986,087
|
0
|
1
|
SLC11A2
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2
|
4891
|
P49281
|
chr12: 50,979,401-51,028,566
|
0
|
1
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
4893
|
P01111
|
chr1: 114,704,469-114,716,894
|
0
|
1
|
NRCAM
|
neuronal cell adhesion molecule
|
4897
|
Q92823
|
chr7: 108,147,623-108,456,717
|
0
|
1
|
NRDC
|
nardilysin convertase
|
4898
|
O43847
|
chr1: 51,789,191-51,878,937
|
0
|
2
|
YBX1
|
Y-box binding protein 1
|
4904
|
P67809
|
chr1: 42,682,427-42,702,349
|
0
|
3
|
NSF
|
N-ethylmaleimide sensitive factor
|
4905
|
P46459
|
chr17: 46,590,669-46,757,464
|
0
|
1
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
4907
|
P21589
|
chr6: 85,449,584-85,495,791
|
0
|
2
|
NTHL1
|
nth-like DNA glycosylase 1
|
4913
|
P78549
|
chr16: 2,039,815-2,047,866
|
0
|
2
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
4914
|
P04629
|
chr1: 156,815,640-156,881,850
|
0
|
1
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
4915
|
Q16620
|
chr9: 84,668,551-85,027,070
|
0
|
3
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
412
|
P08842
|
chrX: 7,219,456-7,354,810
|
1
|
1
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
4919
|
Q01973
|
chr1: 63,774,022-64,181,498
|
0
|
2
|
NTS
|
neurotensin
|
4922
|
P30990
|
chr12: 85,874,295-85,882,992
|
0
|
2
|
NUCB1
|
nucleobindin 1
|
4924
|
Q02818
|
chr19: 48,900,050-48,923,372
|
0
|
1
|
NUCB2
|
nucleobindin 2
|
4925
|
P80303
|
chr11: 17,208,153-17,349,974
|
1
|
1
|
NUP88
|
nucleoporin 88kDa
|
4927
|
Q99567
|
chr17: 5,360,963-5,420,160
|
0
|
1
|
NR4A2
|
nuclear receptor subfamily 4 group A member 2
|
4929
|
P43354
|
chr2: 156,324,432-156,342,348
|
0
|
2
|
OAZ1
|
ornithine decarboxylase antizyme 1
|
4946
|
P54368
|
chr19: 2,269,509-2,273,490
|
0
|
1
|
OAZ2
|
ornithine decarboxylase antizyme 2
|
4947
|
O95190
|
chr15: 64,687,573-64,703,281
|
0
|
1
|
OCRL
|
oculocerebrorenal syndrome of Lowe
|
4952
|
Q01968
|
chrX: 129,539,849-129,592,561
|
0
|
1
|
ODC1
|
ornithine decarboxylase 1
|
4953
|
P11926
|
chr2: 10,439,968-10,448,504
|
0
|
1
|
ARSD
|
arylsulfatase D
|
414
|
P51689
|
chrX: 2,903,970-2,929,351
|
0
|
2
|
ODF2
|
outer dense fiber of sperm tails 2
|
4957
|
Q5BJF6
|
chr9: 128,455,186-128,501,292
|
0
|
1
|
OMD
|
osteomodulin
|
4958
|
Q99983
|
chr9: 92,414,245-92,424,461
|
0
|
1
|
OGDH
|
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide)
|
4967
|
Q02218
|
chr7: 44,606,572-44,709,066
|
0
|
1
|
OGN
|
osteoglycin
|
4969
|
P20774
|
chr9: 92,383,967-92,404,696
|
0
|
3
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
4973
|
P78380
|
chr12: 10,158,301-10,172,138
|
0
|
1
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
4976
|
O60313
|
chr3: 193,593,144-193,697,823
|
0
|
1
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily member 11b
|
4982
|
O00300
|
chr8: 118,923,557-118,952,200
|
1
|
1
|
OPRL1
|
opiate receptor-like 1
|
4987
|
P41146
|
chr20: 64,080,173-64,100,643
|
0
|
1
|
ORC1
|
origin recognition complex subunit 1
|
4998
|
Q13415
|
chr1: 52,372,829-52,404,459
|
0
|
1
|
ORC5
|
origin recognition complex subunit 5
|
5001
|
O43913
|
chr7: 104,126,341-104,208,047
|
0
|
1
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
427
|
Q13510
|
chr8: 18,055,992-18,084,998
|
0
|
1
|
SLC22A18
|
solute carrier family 22 member 18
|
5002
|
Q96BI1
|
chr11: 2,899,721-2,925,246
|
0
|
1
|
ORM1
|
orosomucoid 1
|
5004
|
P02763
|
chr9: 114,323,056-114,326,475
|
0
|
1
|
ORM2
|
orosomucoid 2
|
5005
|
P19652
|
chr9: 114,329,869-114,333,252
|
0
|
1
|
OSBP
|
oxysterol binding protein
|
5007
|
P22059
|
chr11: 59,574,398-59,616,144
|
0
|
1
|
OTX2
|
orthodenticle homeobox 2
|
5015
|
P32243
|
chr14: 56,799,905-56,810,479
|
0
|
2
|
OXCT1
|
3-oxoacid CoA-transferase 1
|
5019
|
P55809
|
chr5: 41,730,065-41,870,519
|
0
|
2
|
OXTR
|
oxytocin receptor
|
5021
|
P30559
|
chr3: 8,750,408-8,769,628
|
0
|
2
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
5025
|
Q99571
|
chr12: 121,209,857-121,234,106
|
0
|
2
|
P4HA1
|
prolyl 4-hydroxylase, alpha polypeptide I
|
5033
|
P13674
|
chr10: 73,007,217-73,096,974
|
0
|
2
|
P4HB
|
prolyl 4-hydroxylase, beta polypeptide
|
5034
|
P07237
|
chr17: 81,843,159-81,860,694
|
0
|
2
|
ACPP
|
acid phosphatase, prostate
|
55
|
P15309
|
chr3: 132,317,367-132,368,298
|
0
|
1
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
429
|
P50553
|
chr12: 102,957,686-102,960,516
|
0
|
1
|
PA2G4
|
proliferation-associated 2G4
|
5036
|
Q9UQ80
|
chr12: 56,104,319-56,113,907
|
1
|
3
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
5037
|
P30086
|
chr12: 118,135,858-118,145,584
|
0
|
5
|
PABPC3
|
poly(A) binding protein, cytoplasmic 3
|
5042
|
Q9H361
|
chr13: 25,095,868-25,099,254
|
0
|
1
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
5045
|
P09958
|
chr15: 90,868,592-90,883,458
|
0
|
1
|
PCSK6
|
proprotein convertase subtilisin/kexin type 6
|
5046
|
P29122
|
chr15: 101,297,142-101,525,202
|
0
|
3
|
PAEP
|
progestagen-associated endometrial protein
|
5047
|
P09466
|
chr9: 135,561,756-135,566,955
|
2
|
0
|
PAFAH1B2
|
platelet activating factor acetylhydrolase 1b catalytic subunit 2
|
5049
|
P68402
|
chr11: 117,144,267-117,176,894
|
0
|
1
|
PAFAH1B3
|
platelet activating factor acetylhydrolase 1b catalytic subunit 3
|
5050
|
Q15102
|
chr19: 42,297,033-42,303,546
|
0
|
1
|
PRDX1
|
peroxiredoxin 1
|
5052
|
Q06830
|
chr1: 45,511,036-45,523,047
|
0
|
3
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
5054
|
P05121
|
chr7: 101,127,089-101,139,266
|
3
|
2
|
ASNA1
|
arsA arsenite transporter, ATP-binding, homolog 1 (bacterial)
|
439
|
O43681
|
chr19: 12,737,139-12,748,323
|
0
|
1
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
5062
|
Q13177
|
chr3: 196,739,857-196,832,647
|
0
|
1
|
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3
|
5063
|
O75914
|
chrX: 110,944,285-111,227,361
|
1
|
2
|
PAM
|
peptidylglycine alpha-amidating monooxygenase
|
5066
|
P19021
|
chr5: 102,753,981-103,031,105
|
0
|
2
|
CNTN3
|
contactin 3
|
5067
|
Q9P232
|
chr3: 74,262,568-74,521,140
|
0
|
1
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
5069
|
Q13219
|
chr9: 116,153,804-116,402,322
|
1
|
2
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
5071
|
O60260
|
chr6: 161,347,420-162,727,771
|
1
|
0
|
PARN
|
poly(A)-specific ribonuclease
|
5073
|
O95453
|
chr16: 14,435,701-14,632,728
|
0
|
1
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
5074
|
Q96IZ0
|
chr12: 79,574,979-79,691,097
|
0
|
2
|
PAX4
|
paired box 4
|
5078
|
O43316
|
chr7: 127,610,292-127,618,114
|
0
|
1
|